Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alveolar macrophage activation and polarization signatures in stable lung transplant recipients and chronic lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Encapsulation of the novel mPGES-1 inhibitor TG554 in acetalated dextran nanoparticles.

RSC advances·2026
Same author

Extrahepatic Gene Editing In Vivo Using Organic Solvent-Free Lipid Nanoparticles.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

A novel agarose-free, standardized generation and versatile ECM characterization of decellularized scaffolds from normal and fibrotic human lung tissue.

Frontiers in bioengineering and biotechnology·2026
Same author

Predicting acetalated dextran nanoparticle features: Controlled synthesis, formulation, and testing in a high-throughput process.

Carbohydrate polymers·2026
Same author

POx-Lipids as an Alternative to PEG-Lipids? Multimethod Assessment of Chemistry and Structure.

Analytical chemistry·2026
Same journal

Reprocessable Disulfide-Based Vitrimers with Adhesive Properties.

Macromolecular rapid communications·2026
Same journal

Micro- and Nanopatterning of Highly Conductive PEDOT Thin Films.

Macromolecular rapid communications·2026
Same journal

From Molecular Structure to Macroscopic Performance: Insights into Polycarbosilane Curing.

Macromolecular rapid communications·2026
Same journal

High-Yield Synthesis of Molecular Bottlebrushes With Block Copolymer Side Chains by the Copper Superoxido Complex Enabled ATRP via a Grafting-From Approach.

Macromolecular rapid communications·2026
Same journal

Chemically and Mechanically Recyclable Polyolefins Incorporating Covalent Adaptable Networks.

Macromolecular rapid communications·2026
Same journal

Designing Thermally Stable DNA Hydrogels via Entropically-Driven Acridine Intercalation.

Macromolecular rapid communications·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

Labeled Nanoparticles Based on Pharmaceutical EUDRAGIT® S 100 Polymers.

Antje Vollrath1, Stephanie Schubert, Norbert Windhab

  • 1Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstr. 10, 07743 Jena, Germany.

Macromolecular Rapid Communications
|May 14, 2011
PubMed
Summary
This summary is machine-generated.

This study details the creation of detectable polymer nanoparticles using P(MAA-r-MMA)(1:2) for advanced drug delivery. These labeled nanocarriers enable precise monitoring of drug pathways within the body.

More Related Videos

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
12:48

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS

Published on: December 27, 2013

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
10:38

Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery

Published on: January 15, 2018

Area of Science:

  • Polymer chemistry
  • Nanotechnology
  • Materials science

Background:

  • Poly(methacrylic acid-co-methyl methacrylate) (P(MAA-r-MMA)(1:2)), known as EUDRAGIT(®) S100, is a key polymer in pharmaceutical applications.
  • Nanoparticle formation via nanoprecipitation is a crucial technique for drug delivery systems.
  • Developing detectable nanocarriers is essential for monitoring drug pathways and enhancing controlled drug delivery.

Purpose of the Study:

  • To investigate the nanoprecipitation of P(MAA-r-MMA)(1:2) for nanoparticle formation.
  • To modify P(MAA-r-MMA)(1:2) nanoparticles with various markers for enhanced detectability.
  • To evaluate the potential of these labeled nanocarriers for drug delivery, sensing, and imaging applications.

Main Methods:

  • Nanoprecipitation was used to form P(MAA-r-MMA)(1:2) nanoparticles.
  • Particles were characterized using Dynamic Light Scattering (DLS), Scanning Electron Microscopy (SEM), and Analytical Ultracentrifugation (AUC).
  • Markers (radicals, fluorescent dyes, near-infrared dyes) were incorporated via physical entrapment or covalent attachment.

Main Results:

  • Characterization confirmed the size, shape, and properties of the obtained nanoparticles.
  • Labeled nanoparticles were successfully prepared using both physical entrapment and covalent attachment methods.
  • In vitro studies demonstrated the biocompatibility of the labeled nanocarriers.

Conclusions:

  • P(MAA-r-MMA)(1:2) can be effectively used to create nanoparticles via nanoprecipitation.
  • Modification with various markers yields detectable polymer-based nanocarrier systems.
  • These labeled nanocarriers show promise for applications in controlled drug delivery, sensing, and medical imaging.